RecruitingNot ApplicableNCT04562194

NeVa ONE Registry Study

NEVA ONE One-Pass Reperfusion With the NeVa Stent-Retriever EMEA Registry

Sponsor

Vesalio

Enrollment

600 participants

Start Date

Jul 1, 2020

Study Type

INTERVENTIONAL

Conditions

Acute Ischemic Stroke

Summary

A prospective, open label study designed to assess the safety, performance and efficacy of thrombus removal in subjects presenting with acute ischemic stroke with the NeVa stent retrievers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called NeVa Stent Retriever for people with acute ischemic stroke. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENeVa Stent Retriever

mechanical neurothrombectomy

Locations(3)

Hospital Espanol de Mendoza

Mendoza, Argentina

Niguarda Hospital

Milan, Italy

Cleveland Clinic Abu Dhabi

Abu Dhabi, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04562194

Related Trials

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07361302246 locations

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

NCT0569124454 locations